Christian Récher

Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML

Alexander E. Perl, Giovanni Martinelli, Jörge E. Cortes et al. · New England Journal of Medicine · 2019 · 1.2K citations · Full text

Medicine, Oncology, Pharmacotherapy +15

International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with &gt;30% blasts

Hervé Dombret, John F. Seymour, Aleksandra Butrym et al. · Blood · 2015 · 1.1K citations · Full text

Medicine, Geriatric Medicine, Pharmacotherapy +2

Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism

Thomas Farge, Estelle Saland, Fabienne de Toni et al. · Cancer Discovery · 2017 · 916 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis

Arnaud Jaccard, Philippe Moreau, Véronique Leblond et al. · New England Journal of Medicine · 2007 · 518 citations

Medicine, Hematology, Oncology +14

Ivosidenib and Azacitidine in <i>IDH1</i> -Mutated Acute Myeloid Leukemia

Pau Montesinos, Christian Récher, Susana Vives et al. · New England Journal of Medicine · 2022 · 483 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10